789 related articles for article (PubMed ID: 17923131)
1. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
[TBL] [Abstract][Full Text] [Related]
2. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
[TBL] [Abstract][Full Text] [Related]
3. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
4. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
[TBL] [Abstract][Full Text] [Related]
5. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.
Kwee J; Elting ME; Schats R; McDonnell J; Lambalk CB
Reprod Biol Endocrinol; 2007 Mar; 5():9. PubMed ID: 17362511
[TBL] [Abstract][Full Text] [Related]
6. Intercycle variability of ovarian reserve tests: results of a prospective randomized study.
Kwee J; Schats R; McDonnell J; Lambalk CB; Schoemaker J
Hum Reprod; 2004 Mar; 19(3):590-5. PubMed ID: 14998957
[TBL] [Abstract][Full Text] [Related]
7. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
Ng EH; Chan CC; Tang OS; Ho PC
Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
[TBL] [Abstract][Full Text] [Related]
8. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
11. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
[TBL] [Abstract][Full Text] [Related]
12. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
13. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
15. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
Singer T; Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
[TBL] [Abstract][Full Text] [Related]
16. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
17. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
[TBL] [Abstract][Full Text] [Related]
18. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
19. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
Jain T; Soules MR; Collins JA
Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
